Mapping and Exploring the Collagen-I Proteostasis Network
Name
nihms-789042.pdf
Size
1.07 MB
Format
Adobe PDF
Checksum (MD5)
1a5912c5d1b6de220ce4e81f55a842c2
Author(s)
DiChiara, Andrew Stephen
Taylor, Rebecca J.
Wong, Madeline Y.
Doan, Ngoc Duc
Del Rosario, Amanda M
Shoulders, Matthew D.
Date Issued
February 2016
Journal
ACS Chemical Biology
Publisher
American Chemical Society (ACS)
Citation
DiChiara, Andrew S. et al. “Mapping and Exploring the Collagen-I Proteostasis Network.” ACS Chemical Biology 11, 5 (March 2016): 1408–1421 © 2016 American Chemical Society
Version
Author's final manuscript
Abstract
Collagen-I is the most abundant protein in the human body, yet our understanding of how the endoplasmic reticulum regulates collagen-I proteostasis (folding, quality control, and secretion) remains immature. Of particular importance, interactomic studies to map the collagen-I proteostasis network have never been performed. Such studies would provide insight into mechanisms of collagen-I folding and misfolding in cells, an area that is particularly important owing to the prominence of the collagen misfolding-related diseases. Here, we overcome key roadblocks to progress in this area by generating stable fibrosarcoma cells that inducibly express properly folded and modified collagen-I strands tagged with distinctive antibody epitopes. Selective immunoprecipitation of collagen-I from these cells integrated with quantitative mass spectrometry-based proteomics permits the first mapping of the collagen-I proteostasis network. Biochemical validation of the resulting map leads to the assignment of numerous new players in collagen-I proteostasis, and the unanticipated discovery of apparent aspartyl-hydroxylation as a new post-translational modification in the N-propeptide of collagen-I. Furthermore, quantitative analyses reveal that Erp29, an abundant endoplasmic reticulum proteostasis machinery component with few known functions, plays a key role in collagen-I retention under ascorbate-deficient conditions. In summary, the work here provides fresh insights into the molecular mechanisms of collagen-I proteostasis, y ielding a detailed roadmap for future investigations. Straightforward adaptations of the cellular platform developed will also enable hypothesis-driven, comparative research on the likely distinctive proteostasis mechanisms engaged by normal and disease-causing, misfolding collagen-I variants, potentially motivating new therapeutic strategies for currently incurable collagenopathies.
MIT Department
Massachusetts Institute of Technology. Department of Chemistry
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1021/ACSCHEMBIO.5B01083
